Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Uses of benzoyl polyhydroxy cyclohexene in preparation of drug compositions

A technology of benzoyl polyhydroxycyclohexene and composition, which is applied in the field of preparation of synergistic pharmaceutical composition against ectopic drug-resistant Staphylococcus aureus, which can solve the problem of severe drug resistance of bacteria

Inactive Publication Date: 2015-09-09
FUDAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Also because of the wide application of norfloxacin in clinical and animal husbandry, bacteria have developed serious drug resistance to it, thus limiting the application of norfloxacin [4]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Uses of benzoyl polyhydroxy cyclohexene in preparation of drug compositions
  • Uses of benzoyl polyhydroxy cyclohexene in preparation of drug compositions
  • Uses of benzoyl polyhydroxy cyclohexene in preparation of drug compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1. Isolation of synergistic compounds EllipeiopsolB and Zeylenol from the leaves of Piper betel

[0036] Take 3.5g extract from the chloroform extract of the 95% ethanol extract of Piperbetle, mix it with 200-300 mesh silica gel for column chromatography, and use 20mL as a fraction. It was eluted with chloroform-acetone (9:1), and fractions 32-36 were collected and marked as Fr02-32. Fr02-32 was separated and eluted with chloroform-methanol (95:5). Fraction 4-5 was collected and recorded as Fr02-32-4, and weighed 430 mg after evaporating to dryness under reduced pressure. Continue to separate Fr02-32-4, elute with chloroform-acetone (9:1), collect fractions 2-5 and fractions 6-10 respectively, and record them as Fr02-32-4-2 and Fr02-32-4 -6, evaporated to dryness under reduced pressure and weighed 160mg and 220mg respectively. Fr02-32-4-2 and Fr02-32-4-6 were purified several times respectively to obtain a white solid Fr02-32-4-2 weighing 20 mg and Fr02-32-4-6...

Embodiment 2

[0037] Embodiment 2, isolating synergistic compound EllipeiopsolB and Zeylenol from plant floret purple jade disc

[0038] 3.34Kg of the dried aerial part of the plant of the genus Uvaria rufa was extracted with chloroform to obtain 482g of green extract. Part of this extract (150 g) was extracted and layered with 50% petroleum ether-alcohol / water solution, and then the alcohol / water layer was extracted with chloroform to obtain 104 g of chloroform sub-extract. 104g of the extract was separated by column chromatography and eluted with chloroform-acetone to obtain five components of Fr-1 to Fr-5. Fr-3 (5 g) was separated by silica gel column chromatography and eluted with chloroform-methanol to obtain nine components of Fr-3-1~Fr-3-9. Fr-3-5 (2.89 g) was further separated by silica gel column chromatography and eluted with dichloromethane-acetone to obtain thirteen components from Fr-3-5-1 to Fr-3-5-13. Fr-3-5-7 (1.22g) was further separated and purified by reverse phase sili...

Embodiment 3

[0043] Embodiment 3, synergistic compound Zeylenol is synthesized with simple chemical raw material

[0044] synthetic route:

[0045]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention belongs to the pharmaceutical field, and relates to a benzoyl polyhydroxy cyclohexene compound and a synergetic antibacterial effect of the benzoyl polyhydroxy cyclohexene compound on efflux pump drug-resistance Staphylococcus aureus. According to the present invention, the compound of the present invention does not have the bacteria growth inhibition effect, and when the compound and antibiotic norfloxacin are subjected to compatibility, based on the bacteria efflux pump drug-resistance mechanism, NorA gene-containing fluoroquinolone-resistant and methicillin-resistant Staphylococcus aureus experimental drug-resistance bacterial SA1199B is used to test, and the results show that the minimum bacteria inhibition concentration valves of the norfloxacin are respectively reduced by 4 times and 16 times through the compounds Zeylenol and Ellipeiopsol B. According to the present invention, the compound Zeylenol provides the same bacteria efflux pump inhibition effect as the positive control drug, and can be used for preparing synergistic antibiotic drugs.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to the use of benzoyl polyhydroxycyclohexene in the preparation of pharmaceutical compositions, in particular to the use of benzoyl polyhydroxycyclohexene in the preparation of synergistic effects of anti-external pump drug-resistant Staphylococcus aureus; especially benzoyl polyhydroxycyclohexene The use of acyl polyhydroxycyclohexene in the preparation of fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus (MRSA) drugs. Background technique [0002] Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common infectious bacteria in hospitals. Today, MRSA is resistant to all lactam antibiotics such as penicillin, but also to macrolides, fluoroquinolones, tetracyclines, etc., making its infection more difficult to treat. Currently, only vancomycin is the only antibiotic available for the treatment of MRSA. Unfortunately, in 2002, MRSA strains completely resi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/496A61K31/235A61P31/04
Inventor 孙仲琳穆青王双英西蒙.吉本斯
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com